German national case collection for familial pancreatic cancer (FaPaCa): ten years experience
- 5 January 2011
- journal article
- Published by Springer Nature in Familial Cancer
- Vol. 10 (2) , 323-330
Abstract
Familial pancreatic cancer (FPC) is a rare hereditary tumor syndrome. The 10-years experience of the national case collection for familial pancreatic cancer of Germany (FaPaCa) is reported. Since 1999 FaPaCa has collected families with at least two first-degree relatives with confirmed pancreatic cancer (PC), who did not fulfill the criteria of other hereditary tumor syndromes. Histopathological verification of tumor diagnoses, and genetic counseling were prerequisites for enrollment of families in FaPaCa. 94 of 452 evaluated families fulfilled the criteria for partaking in FaPaCa. PC represented the sole tumor entity in 38 (40%) families. In 56 families additional tumor types occurred, including breast cancer (n = 28), colon cancer (n = 20) and lung cancer (n = 11). In 70 (74%) families the pattern of inheritance was consistent with an autosomal dominant trait. Compared to the preceding generation, a younger age of onset was observed in the offspring of PC patients (median: 57 vs. 69 years), indicating anticipation. Mutation analyses of BRCA2, PALB2, CDKN2a, RNASEL, STK11, NOD2, CHEK2 and PALLD, revealed deleterious causative germline mutations of BRCA2 and PALB2 in 2 of 70 (3%) and 2 of 41 (4.9%) German FPC families, respectively. Prospective PC screening with EUS, MRI and MRCP detected precancerous lesions (IPMN, multifocal PanIN2/3) or carcinoma in 5.5% (4 of 72) to 12.5% (9 of 72) of individuals at risk, depending on histological verification. Appropriate inclusion of families at high risk for PC in registries, such as FaPaCa, provides a unique and excellent tool to gain clinical and genetic knowledge of FPC. Focused research projects can be conducted most efficiently, when data of different FPC registries are combined.Keywords
This publication has 40 references indexed in Scilit:
- PALB2 mutations in European familial pancreatic cancer familiesClinical Genetics, 2010
- Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma‐prone familiesClinical Genetics, 2010
- Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer familiesFamilial Cancer, 2010
- Screening for familial pancreatic cancer: is doing something better than doing nothing?Gut, 2009
- Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility GeneScience, 2009
- Palladin Mutation Causes Familial Pancreatic Cancer: Absence in European FamiliesPLOS Medicine, 2007
- Palladin Mutation Causes Familial Pancreatic Cancer and Suggests a New Cancer MechanismPLOS Medicine, 2006
- Low Frequency of CHEK2 Mutations in Familial Pancreatic CancerFamilial Cancer, 2006
- The NOD2 3020insC Mutation and The Risk of Familial Pancreatic Cancer?Hereditary Cancer in Clinical Practice, 2004
- CDKN2A Germline Mutations in Familial Pancreatic CancerAnnals of Surgery, 2002